BIO-RAD LABORATORIES, INC. — Director's Dealing 2019

Sep 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-03

Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-04	Bio-Rad A Common Stock	M	500	—	Acquired	14117	Direct
2019-09-04	Bio-Rad A Common Stock	F	206	$335.20	Disposed	13911	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-03	Restricted Stock Units	$0	A	1856	Acquired		Bio-Rad A Common Stock (1856)	Direct
2019-09-03	Non-Qualified Stock Option (right to buy)	$333.34	A	1856	Acquired	2029-09-03	Bio-Rad A Common Stock (1856)	Direct
2019-09-04	Restricted Stock Units	$0	M	500	Disposed		Bio-Rad A Common Stock (500)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.

F5: The restricted stock units vest in five equal annual installments beginning September 4, 2019.